Elevated levels of Gal‐3 in cerebrospinal fluid (CSF) and brain tissue, particularly in neurodegenerative disorders such as frontotemporal dementia (FTD), have drawn attention to its role as a potential mediator of neurodegeneration.23 Here, LGALS3 is linked to frontotemporal dementia.